Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Subviral Agents

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A retrospective analysis of triptan and dhe use for basilar and hemiplegic migraine.

Headache·2016

Same author

Osteopathic manipulative medicine in the treatment of hypertension: an alternative, conventional approach.

Heart disease (Hagerstown, Md.)·2003

Same journal

Medication Usage in Motor Neuron Disease and Spinal Muscular Atrophy: Insights from the Muscular Dystrophy Association Neuromuscular Observational Research Data Hub.

Journal of clinical neuromuscular disease·2026

Same journal

Severe Necrotizing Myositis With Anti-HMGCR and Anti-MDA5 Antibodies Without Cutaneous Involvement.

Journal of clinical neuromuscular disease·2026

Same journal

Diagnostic Nerve Ultrasound of Lateral Femoral Cutaneous Mononeuropathy With Focal Neural and Fascicular Enlargement.

Journal of clinical neuromuscular disease·2026

Same journal

Letter to the Editor: Utility of Smartwatches in Neuromuscular Disease: Current Use and Barriers to Adoption.

Journal of clinical neuromuscular disease·2026

Same journal

When Variants Collide: Mixed Clinical Presentation of Pharyngeal-Cervical-Brachial and Acute Motor Axonal Neuropathy Features in Guillain-Barré Syndrome.

Journal of clinical neuromuscular disease·2026

Same journal

Acute Motor Axonal Neuropathy in Biotinidase Deficiency Complicated by Dietary Restriction.

Journal of clinical neuromuscular disease·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Paraproteinemic neuropathies.

Jebin M Chacko¹, Warren D Spinner

¹Departments of *Neurology daggerInternal Medicine, State University of New York at Stony Brook, Stony Brook, NY.

Journal of Clinical Neuromuscular Disease

|December 17, 2008

Summary

This summary is machine-generated.

Paraproteinemic neuropathies are a group of disorders linked to abnormal proteins. This review covers their causes, including novel antibodies and vasculitis, and discusses evolving treatments like rituximab.

More Related Videos

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Jun 27, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Area of Science:

Neurology
Immunology
Hematology

Background:

Paraproteinemic neuropathies encompass a range of conditions associated with monoclonal gammopathies.
These disorders include POEMS syndrome, multiple myeloma, and Waldenstrom macroglobulinemia, among others.
Pathogenesis involves factors like hepatitis C virus, VEGF, cytokines, novel antibodies, and vasculitis.

Purpose of the Study:

To review the established features of paraproteinemic neuropathies.
To highlight recent advancements and findings in the literature concerning these conditions.

Main Methods:

Literature review of paraproteinemic neuropathies.
Synthesis of information on disease features, pathogenesis, and therapeutic strategies.

Main Results:

Diverse etiologies contribute to paraproteinemic neuropathies.
Therapeutic options have expanded beyond traditional treatments to include targeted therapies.
Recent research identifies novel antibody specificities and vasculitis as contributing factors.

Conclusions:

Paraproteinemic neuropathies are complex disorders with multifactorial causes.
Treatment strategies are evolving, incorporating newer agents like rituximab and bevacizumab.
Continued research is crucial for understanding and managing these challenging neurological conditions.